Recalls published in November 2025
Everything the FDA, USDA FSIS, CPSC and NHTSA announced in November 2025, newest first.
-
Class II · 12 months ago
Alcon Precision1 One-Day Contact Lenses, -2.25D recall: Potential for a weak seal in some units resulting in compromise in sterility
Potential for a weak seal in some units resulting in compromise in sterility.
-
Class II · 12 months ago
Heritage Pharmaceuticals Inc Desipramine Hydrochloride Tablets, USP, 75 mg recall: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible
CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 30 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class III · 12 months ago
Endo USA, Inc. Everolimus tablets 5mg, 28 tablets recall: Failed Impurities/Degradation Specifications: Out of specification
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class II · 12 months ago
Farmakeio Outsourcing LLC Testosterone 87.5 MG, 1 Pellet FOR Subcutaneous Insertion recall: CGMP Deviations: Potential presence of metal particulate matter
CGMP Deviations: Potential presence of metal particulate matter
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 40 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class III · 12 months ago
Endo USA, Inc. Everolimus tablets 10 mg, 28 tablets recall: Failed Impurities/Degradation Specifications: Out of specification
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
-
Class II · 12 months ago
Breckenridge Pharmaceutical, Inc. Duloxetine Delayed-Release Capsules, USP, 60 mg recall: CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment
CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm.
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 10 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class II · 12 months ago
Teva Pharmaceuticals USA, Inc Prazosin Hydrochloride, Capsules, USP, 5 mg recall: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above
CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable…
-
Class II · 12 months ago
Farmakeio Outsourcing LLC Testosterone Regular Release 200 MG recall: CGMP Deviations: Potential presence of metal particulate matter
CGMP Deviations: Potential presence of metal particulate matter
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 20 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class II · 12 months ago
QuVa Pharma, Inc. R.e.c.k. in Sodium Chloride Solution, Total Volume: 50 mL syringe recall: Presence of Particulate Matter
Presence of Particulate Matter
-
Class II · 12 months ago
Farmakeio Outsourcing LLC Testosterone / Triamcinolone Acetonide, 62.5MG/12.5MCG recall: CGMP Deviations: Potential presence of metal particulate matter
CGMP Deviations: Potential presence of metal particulate matter
-
Class II · 12 months ago
Heritage Pharmaceuticals Inc Desipramine Hydrochloride Tablets, USP, 100 mg recall: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible
CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
-
Class II · 12 months ago
Heritage Pharmaceuticals Inc Desipramine Hydrochloride Tablets, USP, 50 mg recall: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible
CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
-
Class II · 12 months ago
Farmakeio Outsourcing LLC Testosterone 200 MG, 1 Pellet FOR Subcutaneous Insertion recall: CGMP Deviations: Potential presence of metal particulate matter
CGMP Deviations: Potential presence of metal particulate matter
-
Class II · 12 months ago
Amerisource Health Services LLC Prazosin Hydrochloride, Capsules, USP, 1 mg recall: Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA)…
-
Class II · 12 months ago
Acme United Corporation Sting Relief Swabs, First Aid Only, 10 Swabs per box recall: Product Mix-up
Product Mix-up
-
Class II · 12 months ago
Sun Pharmaceutical Industries Inc Lisdexamfetamine Dimesylate Capsules, 70 mg recall: Failed Dissolution Specifications: An out of specification results observed
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
-
Class II · 12 months ago
Heritage Pharmaceuticals Inc Desipramine Hydrochloride Tablets, USP, 10 mg recall: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible
CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
-
Class II · 12 months ago
Farmakeio Outsourcing LLC Testosterone / Triamcinolone Acetonide 50MG/10MCG recall: CGMP Deviations: Potential presence of metal particulate matter
CGMP Deviations: Potential presence of metal particulate matter
-
Class II · 12 months ago
Farmakeio Outsourcing LLC Testosterone Regular Release 50 MG recall: CGMP Deviations: Potential presence of metal particulate matter
CGMP Deviations: Potential presence of metal particulate matter
-
Class II · 12 months ago
Farmakeio Outsourcing LLC Testosterone / Triamcinolone Acetonide 87.5MG/17.5MCG recall: CGMP Deviations: Potential presence of metal particulate matter
CGMP Deviations: Potential presence of metal particulate matter